First highly sensitive, small molecule fluorescence probe to evaluate risk, monitor progression of Parkinson's disease
Tuesday, March 4, 2014 - 08:02
in Health & Medicine
The first two-photon, small molecule fluorogenic probe that can serve as a useful tool for the rapid assessment of an individual’s potential risk for Parkinson’s disease has been developed by scientists. The probe can detect with high precision the activity of Monoamine Oxidase B (MAO-B), an enzyme that is found in elevated levels in patients with Parkinson’s disease. This innovation paves the way for the development of less costly non-invasive technologies and devices to help monitor the risk and progression of Parkinson’s disease.